Period Ending | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 |
---|
Total Revenue
|
15,691,000
|
15,767,000
|
14,461,000
|
16,861,000
| Cost of Revenue |
-
|
-
|
-
|
-
| |
Gross Profit
|
15,691,000
|
15,767,000
|
14,461,000
|
16,861,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 12,348,000 | 12,548,000 | 13,445,000 | 12,719,000 |
|
Non Recurring | 3,257,000 | 4,555,000 | 4,220,000 | 3,582,000 |
|
Others | 2,592,000 | 2,790,000 | 2,640,000 | 3,092,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
3,429,000
|
2,143,000
|
1,020,000
|
4,255,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 273,000 | 1,925,000 | 69,000 | 765,000 |
|
Earnings Before Interest And Taxes | 9,143,000 | 9,658,000 | 6,801,000 | 11,051,000 |
|
Interest Expense | 5,441,000 | 5,590,000 | 5,712,000 | 6,031,000 |
|
Income Before Tax | 3,702,000 | 4,068,000 | 1,089,000 | 5,020,000 |
|
Income Tax Expense | 715,000 | 1,006,000 | 91,000 | 1,278,000 |
|
Minority Interest | (40,000) | (126,000) | (42,000) | 28,000 |
|
|
|
Net Income From Continuing Ops | 2,987,000 | 3,062,000 | 998,000 | 3,742,000 | |
|
Non-recurring Events |
|
Discontinued Operations | (1,000) | (5,000) |
-
| 1,000 |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
2,946,000
|
2,931,000
|
956,000
|
3,771,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
2,946,000
|
2,931,000
|
956,000
|
3,771,000
|
|